Role of N6-methyladenine DNA modification in the pathogenesis of infantile hemangioma

Linfeng Zhang, Zhang Jian, Renrong Lv, Xiaowen Liu, Yiliang Wu, Xu Guangqi, Jianhai Bi, Ran HuoChinese 2018 · DOI

Abstract

Objective To investigate whether N6-methyladenine DNA(6-mA DNA) modification is related to the occurrence of infantile hemangiomas (IH) at the epigenetic level. Methods The genomic 6-mA DNA data were obtained by MeDIP and high-throughput sequencing. The 6-mA DNA methylation levels in 3 proliferative hemangioma specimens and adjacent skin tissues were compared by u-test. The functional differences of 6-mA modified genes were analyzed by GO analysis. Results The level of 6-mA DNA modification in IH tissue was higher. The coverage of 6-mA Peaks in the genome was 0.037% in the tumor tissue, and the coverage of 6-mA Peaks in the surrounding skin tissue was 0.013% in the genome. The difference between the two groups was statistically significant (u=5999.87, P=0.00). The gene functions of differentially 6-mA modified genes in tumors were enriched in mesoderm development, stem cell differentiation, mesenchymal development, and cell cycle. These gene functions were closely related to the pathogenesis of IH. Conclusion Abnormal 6-mA DNA modification may be one of the pathogenesis of infantile hemangioma. Key words: N6-methyladenine; DNA methylation; Infantile hemangioma; Pathogenesis
BibTeX
@inproceedings{zhang2018role,
  author = {Linfeng Zhang and Zhang Jian and Renrong Lv and Xiaowen Liu and Yiliang Wu and Xu Guangqi and Jianhai Bi and Ran Huo},
  title = {{Role of N6-methyladenine DNA modification in the pathogenesis of infantile hemangioma}},
  booktitle = {Chinese},
  year = {2018},
  doi = {10.3760/cma.j.issn.1009-4598.2018.11.017},
}

Loading related content...

Figure